The Influencers

By Chuck Dinerstein, MD, MBA — Apr 04, 2023
Social media influencers (SMI) are a growing advertising market, returning nearly six dollars for every dollar invested – a return on investment of 5.78. These SMI are the next step in direct-to-consumer (DTC) marketing. A new study looks at the patient influencers in healthcare.

Social media influencers (SMI) are a growing advertising market, returning nearly six dollars for every dollar invested – a return on investment of 5.78. These SMI are the next step in direct-to-consumer (DTC) marketing. A new study looks at the patient influencers in healthcare.

COVID-19 Face Masks Work, But How Well?

By Fred Lipfert, PhD — Apr 04, 2023
That's a good question. Masks remain one of the non-pharmaceutical means of controlling the spread of infection. But how effective has COVID masking been in practice?

That's a good question. Masks remain one of the non-pharmaceutical means of controlling the spread of infection. But how effective has COVID masking been in practice?

Not Out of the Woods on COVID Threats: Animal Reservoirs of SARS-CoV-2 Pose Unknown Risks to Humans

By Henry I. Miller, MS, MD — Apr 04, 2023
The spread of SARS-CoV-2 infections through many mammal species in the wild raises the specter of deer becoming a SARS-CoV-2 reservoir — a permanent home for the virus and a regular source of outbreaks in other animals, including humans.

The spread of SARS-CoV-2 infections through many mammal species in the wild raises the specter of deer becoming a SARS-CoV-2 reservoir — a permanent home for the virus and a regular source of outbreaks in other animals, including humans.

‘Bold Goals for U.S. Biotechnology and Biomanufacturing’

By Charles R Santerre, Ph.D — Apr 03, 2023
The recent Office of Science and Technology Policy report demonstrates that the federal government is not serious about feeding the country or developing a strong bioeconomy. The White House’s assessment contains decades-old unworkable initiatives. So we ask: Is the administration moving a ‘bold’ and ‘innovative’ agenda – or one simply focusing on climate initiatives, while China advances its bioeconomy?

The recent Office of Science and Technology Policy report demonstrates that the federal government is not serious about feeding the country or developing a strong bioeconomy. The White House’s assessment contains decades-old unworkable initiatives. So we ask: Is the administration moving a ‘bold’ and ‘innovative’ agenda – or one simply focusing on climate initiatives, while China advances its bioeconomy?

ACSH Asks Where’s the Adderall?

By Chuck Dinerstein, MD, MBA — Mar 31, 2023
The shortage of Adderall, an important medication used to treat ADHD – attention deficit/hyperactivity disorder – is a story of supply, demand, the invisible hand of market forces. It’s also about a bureaucracy focused on regulation rather than outcome. It has all the hallmarks of the opioid crisis. We have learned nothing.

The shortage of Adderall, an important medication used to treat ADHD – attention deficit/hyperactivity disorder – is a story of supply, demand, the invisible hand of market forces. It’s also about a bureaucracy focused on regulation rather than outcome. It has all the hallmarks of the opioid crisis. We have learned nothing.

A Chemist Chats with ChatGPT. How Does it Do?

By Josh Bloom — Mar 30, 2023
AI. Blah blah blah. You can’t turn on the news without hearing about it constantly. So I decided to see if it knew chemistry. With a few exceptions, it did very well. Even when I tried to trick it.

AI. Blah blah blah. You can’t turn on the news without hearing about it constantly. So I decided to see if it knew chemistry. With a few exceptions, it did very well. Even when I tried to trick it.

Benzene in Your Shampoo? It’s Not Only Lawyers Who Want to Sue

From the same folks who instigated the class action litigation over Zantac, we now have a new class action suit – this one claiming that dry shampoos contain dangerous levels of benzene, a known carcinogen.

From the same folks who instigated the class action litigation over Zantac, we now have a new class action suit – this one claiming that dry shampoos contain dangerous levels of benzene, a known carcinogen.

Celebrating Norman Borlaug: He Was Always Ahead of His Time

By Henry I. Miller, MS, MD — Mar 30, 2023
Twenty years ago, Nobel Laureate Norman Borlaug wrote about agricultural biotechnology – its promise, importance, over-regulation, and the mindless opposition to it from activists. His words ring true today.

Twenty years ago, Nobel Laureate Norman Borlaug wrote about agricultural biotechnology – its promise, importance, over-regulation, and the mindless opposition to it from activists. His words ring true today.